ORKA – oruka therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Oruka Therapeutics, Inc. (NASDAQ: ORKA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $40.00 price target on the stock.
Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference
Oruka Therapeutics GAAP EPS of -$1.46 misses by $1.08 [Seeking Alpha]
Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Form SC 13D/A Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
Form 4 Oruka Therapeutics, Inc. For: Nov 19 Filed by: Kiselak Tomas
Form 8-K Oruka Therapeutics, Inc. For: Nov 14
Form SC 13G/A Oruka Therapeutics, Inc. Filed by: Avidity Partners Management LP
Form SC 13G/A Oruka Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.